TherapeuticsMD, Inc.TXMDNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-53.4%
5Y CAGR-14.1%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-53.4%/yr
vs -6.9%/yr prior
5Y CAGR
-14.1%/yr
Recent deceleration
Acceleration
-46.6pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 5.63 | -68.8% |
| 2023 | 18.04 | +2401.4% |
| 2022 | 0.72 | -98.7% |
| 2021 | 55.69 | +983.1% |
| 2020 | 5.14 | -57.2% |
| 2019 | 12.01 | -77.5% |
| 2018 | 53.25 | -28.0% |
| 2017 | 73.99 | +26.6% |
| 2016 | 58.45 | -34.4% |
| 2015 | 89.15 | - |